课题基金 / 基金详情

Selective Small Molecule Membrane Transport Using Cavitand Receptors

Selective Small Molecule Membrane Transport Using Cavitand Receptors
使用空腔受体的选择性小分子膜运输
批准号:
8531891
负责人:
Michael P Schramm
金额:
$13.58万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-08 至 2015-02-28

项目摘要

项目成果

Michael P Schramm的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):通过生物膜输送小分子一直是药物化学的一个长期挑战。几种在体外非常有效的药物与人体的运输机制不相容,因为细胞膜被证明是无法穿透的。这种药物的输送可以通过精心设计的合成受体来促进,自然受体是设计的灵感来源。最近的研究表明,间苯二酚空穴能够作为小分子客体的选择性受体,同时定位于磷胆碱(PC)胶束中。PC胶束是直接观察主客体相互作用的有用工具,但它们不能接近生物膜。另一方面,脂泡则是一个更现实的模型。本项目旨在制备一系列可以被荧光标记的单官能团化间苯二酚空穴,以研究荧光标记的受体互补小分子在有序的脂类组装中的运输。空洞和小分子客体将被引入到单层囊泡中,并将利用共聚焦显微镜来评估成功的膜定位和转运。从这些初步研究中获得的知识将应用于哺乳动物细胞膜。使用荧光标记的空洞,我们将能够评估用于细胞膜定位的各种空洞。这些结果将导致新的见解和假设,可以部署到基于细胞的分析,以探索以前的膜耐药候选药物。此外,新的“纳米药物”方法支持探索聚阳离子空穴可以作为直接基因转染载体的作用。这些选择性分子传输的新方法将为改进当前的药物输送方法和设计纳米级医疗设备提供令人兴奋的机会。
英文摘要
DESCRIPTION (provided by applicant): The delivery of small molecules across biological membranes has been a long-standing challenge to medicinal chemistry. Several drugs that are highly effective in vitro are incompatible with the transport mechanisms of the human organism as the cell membrane proves to be impenetrable. The delivery of such drugs could be facilitated by carefully designed synthetic receptors, with natural receptors serving as an inspiration for design. It was recently demonstrated that resorcinarene cavitands are capable of behaving as selective receptors for small-molecule guests while localized in aqueous phosphocholine (PC) micelles. PC micelles serve as a useful tool for the direct observation of host and guest interaction, but they fall short of approximating biological membranes. Lipid vesicles on the other hand, serve as a more realistic model. This project aims to prepare a series of mono-functionalized resorcinarene cavitands that can be fluorescently tagged to study the transport of fluorescently tagged receptor-complementary small molecules across ordered lipid assemblies. Cavitands and small molecule guests will be introduced into unilamellar vesicles and confocal microscopy will be utilized to evaluate successful membrane localization and transport. The knowledge acquired from these initial studies will be applied to mammalian cell membranes. Using fluorescently tagged cavitands we will be able to evaluate a variety of cavitands for cell membrane localization. These results will lead to new insights and hypotheses that can be deployed towards cell based assays to explore previously membrane resistant drug candidates. Additionally, new "nano-medicinal" approaches support exploring roles in which polycationic cavitands can serve as direct genetic transfection vectors. These new approaches to selective molecular transport will provide exciting opportunities towards advancing current drug delivery methods and designing nanoscale medical devices.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ejoc.201400025
发表时间: 2014-05-01
期刊: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
影响因子: 2.8
作者: [Adhikari, Birendra Babu, Fujii, Ayu, Schramm, Michael P.]
通讯作者: Schramm, Michael P.
DOI: 10.1002/ejoc.201403519
发表时间: 2015-04-01
期刊: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
影响因子: 2.8
作者: [Adhikari, Birendra Babu, Roshandel, Sahar, Fujii, Ayu, Schramm, Michael P.]
通讯作者: Schramm, Michael P.
Selective Small Molecule Membrane Transport Using Cavitand Receptors
Selective Small Molecule Membrane Transport Using Cavitand Receptors
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: